Veterinary Medicines

OXYVET 500 mg/pesariu

Authorised
  • Oxytetracycline hydrochloride
Download as PDF

Product identification

Medicine name:
OXYVET 500 mg/pesariu
Active substance:
  • Oxytetracycline hydrochloride
Target species:
  • Cattle (cow)
  • Horse (mare)
  • Pig (female)
  • Sheep (ewe)
  • Goat (adult female)
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Oxytetracycline hydrochloride
    500.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Intrauterine tablet
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle (cow)
      • Milk
        48
        hour
    • Horse (mare)
      • Milk
        48
        hour
    • Pig (female)
    • Sheep (ewe)
      • Milk
        48
        hour
    • Goat (adult female)
      • Milk
        48
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Available in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • PROVET S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • PROVET S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 220114
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 23/08/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."